Home Details
| Official Symbol of Gene | TBX21 |
| Species | Homo sapiens |
| Entrez Gene ID | 30009 |
| Official Full Name | T-box transcription factor 21 |
| Also known as | TBET; IMD88; T-PET; T-bet; TBLYM |
| Gene Type | protein coding |
| dbXrefs | Ensembl:ENSG00000073861 MIM:604895; AllianceGenome:HGNC:11599 |
| Map Location | 17q21.32 |
| Detected Sample | peripheral blood |
| Sample Detail | N/A |
| Detected Method | Real-Time PCR |
| Disease | MS |
| Disease subtype | N/A |
| Population | N/A |
| Sample Size | eight newly diagnosed (one man and seven women) and eight (two men and six women) IFN-1b-treated patients injection and the mean age of the patients was 33.91 + 8.4. Blood collection from IFN-1b-treated patients was performed 24–48 h after IFN1b injection |
| Pubmed ID | 30178232 |
| Year | 2018 |
| Title | Immunoregulatory Effects of Silymarin on Proliferation and Activation of Th1 Cells Isolated from Newly Diagnosed and IFN-1b-Treated MS Patients |
| Expression | up-regulation |
| Risk type | Disease risk |
| Result | IFN-γ level at a concentration of 100 μM in comparison with DMSO. Our findings here clearly show that silymarin is an effective regulator for Th1 response in vitro condition. It not only suppresses Th1 proliferating activity but also inhibits T-bet gene expression and IFN-γ production by these cells |
| Mechanism/Pathway | T-bet gene expression was significantly decreased in Th1 cells isolated from newly diagnosed and IFN-β-treated RRMS patients after treatment with silymarin compared to DMSO control. |

2023,CopyRight © HMU. College of Bioinformatics Science and Technology, Harbin, China.